Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Faulkner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Non-apoptotic death of the <i>C. elegans</i> linker cell is primed by MYRF-1 activation of <i>pqn-41</i>/polyQOlya Yarychkivska, Simin Liu, Lauren Bayer Horowitz, et al.
Leukemia Research|June 18, 2014
Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancersJennifer A Westwood, Geoffrey M Matthews, Jake Shortt, et al.
Cell Reports|May 13, 2014
The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compoundJake Shortt, Andy K Hsu, Benjamin P Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|July 5, 2020
Skin sensitization in silico protocolCandice Johnson, Ernst Ahlberg, Lennart T Anger, et al.
Regulatory Toxicology and Pharmacology : RTP|June 14, 2019
Genetic toxicology in silico protocolCatrin Hasselgren, Ernst Ahlberg, Yumi Akahori, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Non-apoptotic death of the <i>C. elegans</i> linker cell is primed by MYRF-1 activation of <i>pqn-41</i>/polyQOlya Yarychkivska, Simin Liu, Lauren Bayer Horowitz, et al.
Leukemia Research|June 18, 2014
Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancersJennifer A Westwood, Geoffrey M Matthews, Jake Shortt, et al.
Cell Reports|May 13, 2014
The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compoundJake Shortt, Andy K Hsu, Benjamin P Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|July 5, 2020
Skin sensitization in silico protocolCandice Johnson, Ernst Ahlberg, Lennart T Anger, et al.
Regulatory Toxicology and Pharmacology : RTP|June 14, 2019
Genetic toxicology in silico protocolCatrin Hasselgren, Ernst Ahlberg, Yumi Akahori, et al.
Pageof 2